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Dr Karck. There are some data on the importance of sinus
function. From the work of Dr Leyh, who analyzed this aspect
between the Yacoub operation and the David operation compara-
tively, we learned that the lack of sinus function has not affected
the clinical outcome so far. In other words, with the follow-up we
have accumulated so far, we do not see deterioration of the cusps
or any disadvantages that may be attributable to the loss of sinus
function.
Dr Gerald M. Lawrie (Houston, Tex). I enjoyed this beauti-
fully presented article. I wanted to make a brief comment about the
long-term natural history of this disease. Ten years ago, we had the
opportunity to publish a report on a series of 277 patients who
underwent operations at Baylor in the 1960s and 1970s before
composite grafts were prevalent (Lawrie GM, Earle N, DeBakey
ME. Long-term fate of the aortic root and aortic valve after
ascending aneurysm surgery. Ann Surg. 1993;217:711-20). We
ended up with a series of patients with simple tube grafts, with or
without a separate prosthetic aortic valve replacement. As a result,
we had 277 aortic roots and 118 native aortic valves that we were
able to follow for up to 40 years.
What we found was that simple tube graft replacement in the
patients without Marfan syndrome was a very reliable operation;
96% of the roots and their native valves came through 10 years
without any problem. On the other hand, the patients with Marfan
syndrome did not do so well. These patients had an 86% freedom
from reoperation for their root disease and only a 75% survival of
their Marfan valves, which were originally competent. This 25%
incidence of AI at 10 years is very similar to what Dr Tirone David
published last month for his patients undergoing valve-sparing
surgery (de Oliveira NC, David TE, Ivanov J, Armstrong S,
Eriksson MJ, Rakowski H, et al. Results of surgery for aortic root
aneurysm in patients with Marfan syndrome. J Thorac Cardiovasc
Surg. 2003;125:789-96).
Although this isn’t a direct parallel to your article, we did note
several points that would bear on your presentation. The first is that
most of these problems emerged in the 5- to 10-year time interval.
We had very few problems, almost no problems at all, in the 0- to
5-year interval. So I would continue to be cautious about the wide
application of this concept in Marfan syndrome. This is a real
problem. Again, 40 of 277 patients had Marfan syndrome, and
50% of the reoperations in the entire group were in those 40
patients.
I am glad to see you did pay attention to the incidence of
recurrent AI in great detail. I think we need to get back somewhat
parallel to the mitral repair situation in which we report the success
of our reconstructions according to the presence or absence of AI
rather than reoperation rates. AI is serious but sometimes well
tolerated for long periods of time, and I think we need to focus on
whether there is a competent valve or not.
Dr Karck. I agree. We have to wait until we have accumulated
much longer follow-up times. It is possible that beyond 5 years of
follow-up, complications will occur. So far, however, the results
are quite encouraging. Therefore, we will continue to offer this
operation to patients with Marfan syndrome too.
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